comparemela.com

Latest Breaking News On - Jeevan rekha hospital - Page 2 : comparemela.com

Bharat Biotech gets DCGI s nod to conduct intranasal booster dose trials - Jammu Kashmir Latest News | Tourism

New Delhi, Jan 28: The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154. The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) had also recommended the internasal vaccine clinical trials during the last meeting. The NOC letter issued by the DCGI read, “Central Licensing Authority hereby permits Bharat Biotech International limited to conduct clinical trials of the new drug or investigational new drug.” […]

Parents flood Belagavi hospital with calls for children s vaccine | Hubballi News

Parents flood Belagavi hospital with calls for children s vaccine | Hubballi News
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Ravaged by Covid, still Karnataka fails to bump up Covid vaccine drive

Express News Service BENGALURU, MYSURU: While the vaccination drive should have picked up pace with the surge in Covid cases and deaths, the State Government is not close to its targets as yet. None of the four segments categorised for vaccine coverage has reached 30 per cent of respective populations.Starting with healthcare workers on January 16, of the estimated 16 lakh, only 4.77 lakh (4,77,210) have completed vaccinations (both doses), achieving only 29.82 per cent of the target with 11,22,790 remaining. This is the segment that has seen the highest coverage in the State with the remaining categories recording far lower percentages. A mere 2,20,415 (just 1.10 per cent) of the two crore frontline workers across Karnataka have received both doses, leaving 1.97 crore (1,97,79,585) yet to complete the dosage; only 13.28 per cent (22,05,779) have been vaccinated among the 1.66 crore-strong segment of 45-plus age category, leaving 1.43 crore (1,43,94,230) yet to complete the vaccina

20 children successfully undergo trials of indigenous ZyCoV-D vaccine at Karnataka hospital

Express News Service BELAGAVI: Jeevan Rekha Hospital in Belagavi has successfully conducted the first-phase clinical trials of the country s second indigenously-developed COVID-19 vaccine, ZyCoV-D, on 20 children between the age of 12 and 18 years. None of the children who underwent the clinical trials are having any side effects or other health complications two months after the vaccines were administered to them, said Dr Amit Bhate, Director of Jeevan Rekha Hospital.     The hospital was also one of the 12 centres in the country where clinical trials of Covaxin took place successfully last year. Speaking to The New Indian Express, Dr Bhate said the doctors of his hospital were keeping a tab on the condition of all the 20 children for the past two months at regular intervals and found that they were healthy. All the children had been administered three ZyCoV-D doses each during the clinical trials.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.